Mansi Srivastava,
- Faculty, Department of Biotechnology, Amity University Gurugram, Haryana, India
Abstract
The integration of bioinformatics and cellular biology has revolutionized our understanding of disease mechanisms, offering unprecedented opportunities to model complex biological systems. Bioinformatics is an interdisciplinary field that merges biology, computer science, and statistics, offering advanced tools to analyze vast biological datasets. Cellular functions, including gene expression, protein interactions, and metabolic pathways, form the foundation of physiological and pathological states. Disruptions in these processes can result in diseases like cancer, neurodegenerative conditions, and infectious illnesses. By combining these two disciplines, researchers can develop robust disease models that enhance our understanding of disease progression and aid in the identification of therapeutic targets. This article delves into the intersection of bioinformatics and cellular functions, highlighting its applications in disease modeling. It explores genomics, transcriptomics, and proteomics, emphasizing the role of computational tools in identifying disease-linked mutations, analyzing gene expression patterns, and modeling protein interactions. Case studies, including applications in cancer biology, neurodegenerative disorders, and infectious diseases, illustrate the practical implications of bioinformatics-driven research. Emerging technologies, such as single-cell omics, machine learning, and multi-omics integration are transforming the field, enabling more precise and personalized disease models. Despite these advancements, challenges remain. Issues, such as data integration, computational limitations, and ethical considerations require attention to ensure the reliability and applicability of bioinformatics approaches. The article also discusses potential solutions, including the development of advanced algorithms, collaborative databases, and interdisciplinary research initiatives. In summary, the convergence of bioinformatics and cellular functions forms a dynamic, rapidly advancing field with immense potential to transform medical research and healthcare. By addressing existing challenges and leveraging emerging technologies, researchers can pave the way for groundbreaking advancements in disease modeling, leading to improved diagnostic tools, targeted therapies, and ultimately, better patient outcomes. This intersection will remain a cornerstone of biomedical innovation in the coming decades.
Keywords: Bioinformatic, cellular functions, protein interactions, transcriptomics, single-cell omics
[This article belongs to International Journal of Cell Biology and Cellular Functions ]
Mansi Srivastava. The Intersection of Bioinformatics and Cellular Function in Disease Modeling. International Journal of Cell Biology and Cellular Functions. 2024; 02(02):1-7.
Mansi Srivastava. The Intersection of Bioinformatics and Cellular Function in Disease Modeling. International Journal of Cell Biology and Cellular Functions. 2024; 02(02):1-7. Available from: https://journals.stmjournals.com/ijcbcf/article=2024/view=190888
References
1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403–10.
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. Nat Gen. 2000;25(1):25–9.
3. Ayers KL, Cordell HJ. SNP selection in genome‐wide and candidate gene studies via penalized logistic regression. Gen Epidemiol. 2010;34(8):879–91.
4. Barabási AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Gen. 2011;12(1):56–68.
5. Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, et al. The NIH roadmap epigenomics mapping consortium. Nat Biotech. 2010;28(10):1045–8.
6. Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nat Biotech. 2016;34(5):525–7.
7. Chatr-Aryamontri A, Oughtred R, Boucher L, Rust J, Chang C, Kolas NK, et al. The BioGRID interaction database: 2017 update. Nucl Acid Res. 2017;45(D1):D369–79.
8. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012;148(6):1293–307.
9. Uusküla-Reimand L, Lee CA, Oh RH, Klein ZP, Adler N, Alvi SA, et al. Topoisomerase IIb binding underlies frequently mutated elements in cancer genomes. bioRxiv. 2024:2024-11.
10. Eddy SR. Profile hidden Markov models. Bioinform. 1998;14(9):755–63.
11. Eddy SR. Hidden markov models. Curr Opin Struct Biol. 1996;6(3):361–5.
12. Beck DE, Agama K, Marchand C, Chergui A, Pommier Y, Cushman M. Synthesis and biological evaluation of new carbohydrate-substituted indenoisoquinoline topoisomerase I inhibitors and improved syntheses of the experimental anticancer agents indotecan (LMP400) and indimitecan (LMP776). J Med Chem. 2014;57(4):1495–512.
13. Finn RD, Attwood TK, Babbitt PC, Bateman A, Bork P, Bridge AJ, et al. InterPro in 2017—beyond protein family and domain annotations. Nucleic acids research. 2017;45(D1):D190–9.
14. Goecks J, Nekrutenko A, Taylor J, Galaxy Team team@ galaxyproject.org. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Gen Biol. 2010;11:1–3.
15. Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Gen Biol. 2017;18:1–5.
16. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucl Acid Res. 2000;28(1):27–30.
17. Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–43.
18. Kinsella RJ, Kähäri A, Haider S, Zamora J, Proctor G, Spudich G, et al. Ensembl BioMarts: a hub for data retrieval across taxonomic space. Database. 2011;2011:bar030.
19. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Meth. 2012;9(4):357–9.
20. Li H, Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics. 2009;25(14):1754–60.
21. Wang H, Aragam B, Xing EP. Trade-offs of linear mixed models in genome-wide association studies. J Comput Biol. 2022;29(3):233–42.
22. MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS catalog). Nucl Acid Res. 2017;45(D1):D896–901.
23. Margulies M, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature. 2005;437(7057):376–80.
24. Meyer M, Kircher M. Illumina sequencing library preparation for highly multiplexed target capture and sequencing. Cold Spr Harb Protoc. 2010;2010(6):pdb-rot5448.
25. O‘brien KP, Remm M, Sonnhammer EL. Inparanoid: a comprehensive database of eukaryotic orthologs. Nucl Acid Res. 2005;33(suppl_1):D476–80.
26. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, et al. Overview of the HUPO plasma proteome project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database. Proteomics. 2005;5(13):3226–45.
27. Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotech. 2015;33(3):290–5.
28. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26(6):841–2.
29. Sanger F, Coulson AR. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol. 1975;94(3):441–8.
30. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, et al. Global quantification of mammalian gene expression control. Nature. 2011;473(7347):337–42.
31. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research. 2003;13(11):2498–504.
32. Sims D, Sudbery I, Ilott NE, Heger A, Ponting CP. Sequencing depth and coverage: key considerations in genomic analyses. Nat Rev Gen. 2014;15(2):121–32.
33. Stephens ZD, Lee SY, Faghri F, Campbell RH, Zhai C, Efron MJ, et al. Big data: astronomical or genomical? PLoS Biol. 2015;13(7):e1002195.
34. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Nat Acad Sci. 2005;102(43):15545–50.
35. Sun YV, Hu YJ. Integrative analysis of multi-omics data for discovery and functional studies of complex human diseases. Adv Gen. 2016;93:147–90.
36. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330.
37. Tomczak K, Czerwińska P, Wiznerowicz M. Review the cancer genome atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol/Współczesna Onkol. 2015;2015(1):68–77.
| Volume | 02 |
| Issue | 02 |
| Received | 26/11/2024 |
| Accepted | 03/12/2024 |
| Published | 26/12/2024 |
Login
PlumX Metrics
